Shares of DexCom Inc. advanced 6.00% to $58.13 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.21% to 6,846.61 and the Dow ...
StockStory.org on MSN
AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an ...
These healthcare stocks have long-term and profitable growth runways.
Zacks.com on MSN
DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal
DexCom receives FDA clearance for DexCom Smart Basal titration software module, which optimizes basal insulin dose in type 2 ...
Ever wondered if DexCom is now a bargain or still priced for perfection? Let's get under the hood to see if the recent headlines match up with what the numbers are really saying. The stock has seen ...
The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that securities class action lawsuits have been ...
Weeks after launching its first open call for diabetes advocates, Dexcom is spotlighting the resulting group of 16 people in ...
In honor of National Diabetes Awareness Month, DAV (Disabled American Veterans) announced today a new strategic partnership with Dexcom, the global leader in glucose biosensing. As part of the ...
Since last year, DexCom ( DXCM +5.54%) has faced a series of issues that have sunk its stock price. The medical device ...
Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...
The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that securities class action lawsuits have been filed against DexCom, Inc. (“DexCom”) ( NASDAQ: DXCM) on behalf of those who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback